<p>At the termination of 3 months treatment, female NZB/W F<sub>1</sub> mice in vehicle and SM934 (10 mg/kg) treated groups were randomly and averagely divided into 3 sub-groups. Spleens of each sub-group were pooled together. (A) Surface CD4 and intracellular FoxP3 expressions in splenocytes. (B) Statistical results of percentage of CD4<sup>+</sup>FoxP3<sup>+</sup> population in splenocytes. (C) Real-time PCR analysis of FoxP3 mRNA expression in purified CD4<sup>+</sup> T cells. Shown are mean ± SD, n = 3 in each treated group. * = <i>P</i><0.05 versus vehicle.</p
<p>Single cell suspension from spleen, tumor draining lymph nodes, and tumor of control and MIP trea...
<p><b>A</b>) Representative FACS plots illustrating effects of Flt3L-treatment on splenic and nodal ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
<p>At the termination of 3 months treatment, female NZB/W F<sub>1</sub> mice in vehicle and SM934 (1...
<p>(A) Vehicle and SM934 treated mice were given daily i.p. injection of BrdU for 3 days from day 17...
<p>Splenocytes from immunized mice treated with vehicle or SM934 were isolated at the peak of diseas...
<p>[A] The data are presented as percentage of Treg cells -CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>...
<p>Single cell suspensions of nucleated splenocytes from intact (A-F) or BM chimeric (G-L) mice were...
<p>A) Percentage of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg cells in individual spleen...
<p>At the termination of 3 months treatment, female NZB/W F<sub>1</sub> mice in vehicle and SM934 (1...
<p>The percentage of Foxp3<sup>+</sup> Treg cells was significantly increased upon FTY720 induction ...
<p>The lymphocytes isolated from the MLN (A) and spleen (B) of the treated mice were stained with fl...
<p>Flow cytometry showing the percentages (A, B) and absolute numbers (C) of CD4<sup>+</sup>CD25<sup...
<p>Splenocytes from naïve mice were stimulated <i>in vitro</i> with 3 µg/mL CpG, R848, or both for 4...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>Single cell suspension from spleen, tumor draining lymph nodes, and tumor of control and MIP trea...
<p><b>A</b>) Representative FACS plots illustrating effects of Flt3L-treatment on splenic and nodal ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...
<p>At the termination of 3 months treatment, female NZB/W F<sub>1</sub> mice in vehicle and SM934 (1...
<p>(A) Vehicle and SM934 treated mice were given daily i.p. injection of BrdU for 3 days from day 17...
<p>Splenocytes from immunized mice treated with vehicle or SM934 were isolated at the peak of diseas...
<p>[A] The data are presented as percentage of Treg cells -CD4<sup>+</sup>CD25<sup>+</sup>FOXP3<sup>...
<p>Single cell suspensions of nucleated splenocytes from intact (A-F) or BM chimeric (G-L) mice were...
<p>A) Percentage of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg cells in individual spleen...
<p>At the termination of 3 months treatment, female NZB/W F<sub>1</sub> mice in vehicle and SM934 (1...
<p>The percentage of Foxp3<sup>+</sup> Treg cells was significantly increased upon FTY720 induction ...
<p>The lymphocytes isolated from the MLN (A) and spleen (B) of the treated mice were stained with fl...
<p>Flow cytometry showing the percentages (A, B) and absolute numbers (C) of CD4<sup>+</sup>CD25<sup...
<p>Splenocytes from naïve mice were stimulated <i>in vitro</i> with 3 µg/mL CpG, R848, or both for 4...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>Single cell suspension from spleen, tumor draining lymph nodes, and tumor of control and MIP trea...
<p><b>A</b>) Representative FACS plots illustrating effects of Flt3L-treatment on splenic and nodal ...
<p>Both mLN and spleen cell suspensions were prepared 14 days after the start of the DSS and OVA tre...